4//SEC Filing
Dube Michael P 4
Accession 0000950170-24-112980
CIK 0001652130other
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 5:29 PM ET
Size
5.3 KB
Accession
0000950170-24-112980
Insider Transaction Report
Form 4
Dube Michael P
VP, Chief Accounting Officer
Transactions
- Sale
Common Stock
2024-10-02$19.01/sh−2,012$38,248→ 47,012 total
Footnotes (2)
- [F1]Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on October 1, 2024, and does not represent a volitional trade by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.95 to $19.01, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 2, 2024 at each separate price.
Documents
Issuer
Intellia Therapeutics, Inc.
CIK 0001652130
Entity typeother
Related Parties
1- filerCIK 0002019493
Filing Metadata
- Form type
- 4
- Filed
- Oct 3, 8:00 PM ET
- Accepted
- Oct 4, 5:29 PM ET
- Size
- 5.3 KB